|
FAM133B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.86202181346107E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.09420275460093E-11 |
| Normal-vs-Stage2 |
9.2389984551744E-11 |
| Normal-vs-Stage3 |
5.21693799271361E-13 |
| Normal-vs-Stage4 |
6.31161789499401E-13 |
| Stage1-vs-Stage2 |
2.847400E-01 |
| Stage1-vs-Stage3 |
2.569900E-02 |
| Stage1-vs-Stage4 |
2.375800E-02 |
| Stage2-vs-Stage3 |
6.003600E-01 |
| Stage2-vs-Stage4 |
3.759600E-01 |
| Stage3-vs-Stage4 |
6.700800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34892138862142E-12 |
| Normal-vs-AfricanAmerican |
1.66739999996057E-06 |
| Normal-vs-Asian |
1.00089999621744E-08 |
| Caucasian-vs-AfricanAmerican |
7.956000E-01 |
| Caucasian-vs-Asian |
2.959000E-01 |
| AfricanAmerican-vs-Asian |
6.739600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.6488147492928E-13 |
| Normal-vs-Female |
1.23679955166267E-11 |
| Male-vs-Female |
1.187550E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.38129951920973E-10 |
| Normal-vs-Age(41-60Yrs) |
8.80984174500554E-12 |
| Normal-vs-Age(61-80Yrs) |
1.65178981603731E-12 |
| Normal-vs-Age(81-100Yrs) |
3.99200006384604E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.413800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.589200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.275810E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.769800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.166500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.525200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.059180E-03 |
| Classical-VS-Follicular |
9.729400E-01 |
| Classical-VS-Other |
7.441800E-01 |
| Classical-VS-Normal |
1.63539959352477E-10 |
| Tall-VS-Follicular |
8.501500E-03 |
| Tall-VS-Other |
6.667900E-02 |
| Tall-VS-Normal |
1.8286483438601E-12 |
| Follicular-VS-Other |
8.082400E-01 |
| Follicular-VS-Normal |
1.27210020295365E-10 |
| Other-VS-Normal |
9.979200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.52895490607352E-12 |
| Normal-vs-N1 |
4.04350000149378E-08 |
| N0-vs-N1 |
8.662300E-02 |
|
|
